Allergan, is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live good life.
Type
Public
HQ
Dublin, IE
Founded
1948
Size (employees)
16,700 (est)-46%
Allergan was founded in 1948 and is headquartered in Dublin, IE
Report incorrect company information

Key People/Management at Allergan

Brenton L. Saunders

Brenton L. Saunders

Chairman, President and CEO, Allergan
William Meury

William Meury

EVP & Chief Commercial Officer
Matt Walsh

Matt Walsh

EVP & Chief Financial Officer
A. Robert D. Bailey

A. Robert D. Bailey

EVP & Chief Legal Officer and Corporate Secretary
Karen L. Ling

Karen L. Ling

EVP & Chief Human Resources Officer
C. David Nicholson

C. David Nicholson

EVP & Chief R&D Officer
Show more

Allergan Office Locations

Allergan has offices in Parsippany-Troy Hills and Dublin
Parsippany-Troy Hills, US
400 Interpace Pkwy
Show all (2)
Report incorrect company information

Allergan Financials and Metrics

Allergan Revenue

USD

Net income (Q2, 2018)

(754 m)

Market capitalization (16-Aug-2018)

62.5 b

Closing stock price (16-Aug-2018)

184.2
Allergan's current market capitalization is $62.5 b.
USDQ2, 2018

General and administrative expense

630 m

Operating expense total

630 m

Net Income

(754 m)
Annual
USDFY, 2013FY, 2014

Cash

3 b4.9 b

Accounts Receivable

883.3 m914.5 m

Inventories

285.3 m296 m

Current Assets

5.3 b6.9 b
Quarterly
USDQ1, 2018Q2, 2018

Current Liabilities

5.8 b

Total Equity

72.3 b71.3 b
USDFY, 2013FY, 2014

Net Income

988.7 m1.5 b

Depreciation and Amortization

254.6 m248.1 m

Inventories

(27 m)(44 m)

Accounts Payable

37.4 m1.9 m
Show all financial metrics

Allergan Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Elastagen February 07, 2018$95 m
ZELTIQ Aesthetics (CoolSculpting) February 15, 2017$2.48 b
Report incorrect company information

Allergan Online and Social Media Presence

Embed Graph
Report incorrect company information

Allergan News and Updates

Allergan eyes middle class to boost Botox sales in Indian market

While the Botox segment is growing annually at around 20-25% in the country, Allergan India's aesthetics business is growing at 60%

FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline

-- Positive vote for both the skin infections and pneumonia indications -- -- FDA decision expected in early October 2018 --

Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process

DUBLIN, Aug. 8, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Michael E. Greenberg, PhD will join its Board of Directors effective immediately, as part of the company's ongoing board refreshment process. Dr. Greenberg is the Nathan Marsh Pusey Professor of...

Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101

  Reinforces both Allergan’s and Editas’ continued commitment to developing innovative treatments for unmet needs in eye care

BetterInvesting Magazine Releases October Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use

MADISON HEIGHTS, Mich., Aug. 3, 2018 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan plc (NYSE: AGN) as its October 2018 "Stock to Study" and CVS Health Corporation (NYSE: CVS) as its October 2018 "Undervalued...

Corrected - Allergan sues Pfizer over costs of opioid litigation

(Reuters) - Allergan Plc on Thursday sued Pfizer Inc to force its rival to cover any damages Allergan is forced to pay as a result of hundreds of lawsuits claiming it deceptively marketed an opioid it acquired from a company Pfizer bought.
Show more
Report incorrect company information

Allergan Company Life and Culture

Report incorrect company information